Biomed-Lublin Wytwórnia Surowic I Szczepionek SA Stock: price and insider trades · Poland

Biomed-Lublin Wytwórnia Surowic I Szczepionek SA is a Health Care company. Its directors and officers file their transactions with KNF. The last twelve months, up to 7 November 2026, brought 6 filings signed by 1 insider.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Across the 561 companies tracked on its exchange, the median is 3 filings; at 6 filings, this issuer sits above that mark.

Over the last twelve months, not one insider purchase of Biomed-Lublin Wytwórnia Surowic I Szczepionek SA stock was filed.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by KNF. They describe what insiders did and are not a recommendation.